| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.083 | 627 | 2.104 | 13.164 | 43.711 | 108.111 | 223.664 | 259.876 | 237.046 |
| Total Income - EUR | - | 2.276 | 627 | 2.108 | 13.164 | 43.714 | 108.773 | 244.595 | 291.149 | 476.823 |
| Total Expenses - EUR | - | 7.381 | 1.359 | 613 | 3.207 | 22.064 | 68.686 | 225.498 | 235.871 | 422.963 |
| Gross Profit/Loss - EUR | - | -5.105 | -731 | 1.495 | 9.957 | 21.649 | 40.087 | 19.097 | 55.278 | 53.860 |
| Net Profit/Loss - EUR | - | -5.150 | -750 | 1.431 | 9.562 | 21.238 | 38.999 | 16.651 | 52.813 | 41.735 |
| Employees | - | 2 | 1 | 0 | 0 | 1 | 2 | 4 | 5 | 4 |
Check the financial reports for the company - Zascort-Health Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 83 | 44 | 12.632 | 27.728 | 70.167 | 291.668 | 307.091 | 299.036 | 104.711 |
| Current Assets | - | 1.809 | 1.507 | -3 | -1.124 | 5.499 | 36.699 | 23.534 | 22.061 | 24.333 |
| Inventories | - | 961 | 945 | 0 | 0 | 0 | 312 | 5.560 | 5.349 | 657 |
| Receivables | - | 357 | 0 | 0 | 0 | 4.759 | 22.149 | 478 | 10.079 | 1.761 |
| Cash | - | 491 | 562 | -3 | -1.124 | 739 | 14.238 | 17.497 | 6.633 | 21.915 |
| Shareholders Funds | - | -5.106 | -5.770 | 1.474 | 11.008 | 32.038 | 64.383 | 19.387 | 64.415 | 88.792 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 6.998 | 7.320 | 11.155 | 15.596 | 43.628 | 263.984 | 311.238 | 256.683 | 40.252 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Zascort-Health Srl